A genetic therapy has improved the vision of patients who would otherwise have gone blind.

A clinical study by British scientists has shown that the improvement is long-lasting and so the therapy is suitable to be offered as a treatment.

The researchers will apply for approval to begin trials to treat more common forms of blindness next year.